1. Home
  2. WST vs STX Comparison

WST vs STX Comparison

Compare WST & STX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • STX
  • Stock Information
  • Founded
  • WST 1923
  • STX 1978
  • Country
  • WST United States
  • STX Singapore
  • Employees
  • WST N/A
  • STX N/A
  • Industry
  • WST Medical/Dental Instruments
  • STX Electronic Components
  • Sector
  • WST Health Care
  • STX Technology
  • Exchange
  • WST Nasdaq
  • STX Nasdaq
  • Market Cap
  • WST 18.9B
  • STX 33.0B
  • IPO Year
  • WST N/A
  • STX 2002
  • Fundamental
  • Price
  • WST $261.57
  • STX $208.58
  • Analyst Decision
  • WST Strong Buy
  • STX Buy
  • Analyst Count
  • WST 8
  • STX 20
  • Target Price
  • WST $329.43
  • STX $161.95
  • AVG Volume (30 Days)
  • WST 549.8K
  • STX 3.5M
  • Earning Date
  • WST 10-23-2025
  • STX 10-21-2025
  • Dividend Yield
  • WST 0.34%
  • STX 1.36%
  • EPS Growth
  • WST N/A
  • STX 328.48
  • EPS
  • WST 6.68
  • STX 6.77
  • Revenue
  • WST $2,960,200,000.00
  • STX $9,097,000,000.00
  • Revenue This Year
  • WST $6.28
  • STX $16.54
  • Revenue Next Year
  • WST $6.02
  • STX $9.96
  • P/E Ratio
  • WST $38.69
  • STX $31.18
  • Revenue Growth
  • WST 2.90
  • STX 38.86
  • 52 Week Low
  • WST $187.43
  • STX $63.19
  • 52 Week High
  • WST $352.33
  • STX $215.20
  • Technical
  • Relative Strength Index (RSI)
  • WST 62.71
  • STX 81.47
  • Support Level
  • WST $254.35
  • STX $163.86
  • Resistance Level
  • WST $264.06
  • STX $215.20
  • Average True Range (ATR)
  • WST 5.75
  • STX 6.42
  • MACD
  • WST 0.72
  • STX 2.67
  • Stochastic Oscillator
  • WST 88.88
  • STX 87.11

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About STX Seagate Technology Holdings PLC (Ireland)

Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.

Share on Social Networks: